Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder

Banner for the International Psoriasis Council featuring the text Councilor Spotlight, with headshots of IPC Councilors—a woman and a man—in separate frames below. The background showcases colorful geometric patterns in the corners.

Two New Councilors Expand IPC’s Global Expertise

The International Psoriasis Council (IPC) welcomes two new Councilors whose work reflects the evolving landscape of psoriasis research and care, with a focus on data-driven, evidence-based approaches.

Dr. Mari Løset and Dr. Maxwell Sauder join IPC’s global network, bringing complementary expertise in translational research, data science, and oncodermatology, while expanding IPC’s presence to Norway.

Mari Løset, MD, PhD

Norwegian University of Science and Technology and St. Olavs Hospital, Trondheim University Hospital

Trondheim, Norway

IPC Councilor

Bio
Dr. Mari Løset is a consultant dermatologist and researcher based in Trondheim, Norway, with a focus on integrating multi-omic data from large-scale biobanks to advance the understanding of inflammatory skin diseases such as psoriasis. As an IPC Councilor, Dr. Løset brings expertise in translational science, a collaborative global perspective, and a commitment to advancing patient-centered care through data-driven innovation.

Maxwell Sauder, MD

University of Toronto

Toronto, Ontario, Canada

IPC Councilor

Bio
Dr. Maxwell Sauder is a Toronto-based dermatologist, Assistant Professor at the University of Toronto, and oncodermatologist at the Princess Margaret Cancer Centre. His work spans inflammatory skin disease and the dermatologic complications of cancer therapies. As an IPC Councilor, Dr. Sauder contributes clinical trial expertise, a broad therapeutic perspective, and expertise at the intersection of inflammation and oncology to support patient-centered, evidence-based care.

Strengthening IPC’s Global Perspective

Together, Drs. Løset and Sauder enhance IPC’s ability to address the complexities of psoriatic disease across diverse patient populations and clinical contexts. Their combined expertise reinforces IPC’s commitment to advancing research, improving clinical decision-making, and ultimately elevating standards of care for people living with psoriasis worldwide.

Categories

Recent Posts

Highlights from the 2026 European Academy of Dermatology and Venereology (EADV) Congress: Personalized Medicine, Therapeutic Advances, and Late-Breaking Research

VIEW

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

VIEW

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe
Psoriasis Masterclass North America - April 10 - 11, 2027 in Dallas, Texas. Limited to 60 participants. Register now!

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026